Cargando…

miRNA-223-3p regulates NLRP3 to promote apoptosis and inhibit proliferation of hep3B cells

Hepatocellular carcinoma (HCC) is a major malignant tumor type with a high incidence and mortality. Infection with hepatitis virus is a high-risk factor. Previous studies have demonstrated that microRNA (miR)-223 was downregulated in HCC tissues. NOD-like receptor family, pyrin domain containing 3 (...

Descripción completa

Detalles Bibliográficos
Autores principales: Wan, Lingfeng, Yuan, Xin, Liu, Mantian, Xue, Boyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5792760/
https://www.ncbi.nlm.nih.gov/pubmed/29467847
http://dx.doi.org/10.3892/etm.2017.5667
_version_ 1783296802768814080
author Wan, Lingfeng
Yuan, Xin
Liu, Mantian
Xue, Boyu
author_facet Wan, Lingfeng
Yuan, Xin
Liu, Mantian
Xue, Boyu
author_sort Wan, Lingfeng
collection PubMed
description Hepatocellular carcinoma (HCC) is a major malignant tumor type with a high incidence and mortality. Infection with hepatitis virus is a high-risk factor. Previous studies have demonstrated that microRNA (miR)-223 was downregulated in HCC tissues. NOD-like receptor family, pyrin domain containing 3 (NLRP3)-is a potential target of miR-223 and has a vital role in hepatitis infection. The present study was performed to investigate the role of miR-223 in the proliferation and apoptosis of HCC cells through regulating NLRP3. A dual luciferase reporter assay was performed to confirm the direct interaction between miR-223-3p and the 3′ untranslated region of NLRP3 mRNA. Hep3B cells were then transfected with miR-223 mimics and the proliferation and apoptosis were determined by an MTT and a flow cytometric assay, respectively. The expression of NLRP3 and caspase-1 was analyzed at the mRNA as well as at the protein level by reverse transcription-quantitative polymerase chain reaction and western blot analysis, respectively. The secretion of interleukin (IL)-1β and IL-18 in the culture supernatants was measured by ELISA. The dual luciferase assay confirmed NLRP3 as a direct target of miR-223. Overexpression of miR-223 in hep3B cells significantly suppressed cell proliferation and promoted apoptosis. Furthermore, the expression of NLRP3 was downregulated by miR-223 transfection. Certain downstream factors of the NLRP3 pathway were also downregulated following overexpression of miR-223. Caspase-1 was decreased at the transcriptional level and the cleaved caspase-1 was decreased at the protein level. Secretion of IL-1β and IL-18 into the culture medium by cells transfected with miR-223 was lower than that by the control cells. In conclusion, the tumor suppressor role of miR-223 was associated with the regulation of NLRP3 inflammasome components. miR-223 inhibited HCC cell proliferation and promoted apoptosis by directly targeting NLRP3. Downstream production of caspase-1, IL-1β and IL-18 were also repressed by miR-223. These results provided insight into the association between the innate immune system and the genesis of HCC.
format Online
Article
Text
id pubmed-5792760
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-57927602018-02-21 miRNA-223-3p regulates NLRP3 to promote apoptosis and inhibit proliferation of hep3B cells Wan, Lingfeng Yuan, Xin Liu, Mantian Xue, Boyu Exp Ther Med Articles Hepatocellular carcinoma (HCC) is a major malignant tumor type with a high incidence and mortality. Infection with hepatitis virus is a high-risk factor. Previous studies have demonstrated that microRNA (miR)-223 was downregulated in HCC tissues. NOD-like receptor family, pyrin domain containing 3 (NLRP3)-is a potential target of miR-223 and has a vital role in hepatitis infection. The present study was performed to investigate the role of miR-223 in the proliferation and apoptosis of HCC cells through regulating NLRP3. A dual luciferase reporter assay was performed to confirm the direct interaction between miR-223-3p and the 3′ untranslated region of NLRP3 mRNA. Hep3B cells were then transfected with miR-223 mimics and the proliferation and apoptosis were determined by an MTT and a flow cytometric assay, respectively. The expression of NLRP3 and caspase-1 was analyzed at the mRNA as well as at the protein level by reverse transcription-quantitative polymerase chain reaction and western blot analysis, respectively. The secretion of interleukin (IL)-1β and IL-18 in the culture supernatants was measured by ELISA. The dual luciferase assay confirmed NLRP3 as a direct target of miR-223. Overexpression of miR-223 in hep3B cells significantly suppressed cell proliferation and promoted apoptosis. Furthermore, the expression of NLRP3 was downregulated by miR-223 transfection. Certain downstream factors of the NLRP3 pathway were also downregulated following overexpression of miR-223. Caspase-1 was decreased at the transcriptional level and the cleaved caspase-1 was decreased at the protein level. Secretion of IL-1β and IL-18 into the culture medium by cells transfected with miR-223 was lower than that by the control cells. In conclusion, the tumor suppressor role of miR-223 was associated with the regulation of NLRP3 inflammasome components. miR-223 inhibited HCC cell proliferation and promoted apoptosis by directly targeting NLRP3. Downstream production of caspase-1, IL-1β and IL-18 were also repressed by miR-223. These results provided insight into the association between the innate immune system and the genesis of HCC. D.A. Spandidos 2018-03 2017-12-21 /pmc/articles/PMC5792760/ /pubmed/29467847 http://dx.doi.org/10.3892/etm.2017.5667 Text en Copyright: © Wan et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Wan, Lingfeng
Yuan, Xin
Liu, Mantian
Xue, Boyu
miRNA-223-3p regulates NLRP3 to promote apoptosis and inhibit proliferation of hep3B cells
title miRNA-223-3p regulates NLRP3 to promote apoptosis and inhibit proliferation of hep3B cells
title_full miRNA-223-3p regulates NLRP3 to promote apoptosis and inhibit proliferation of hep3B cells
title_fullStr miRNA-223-3p regulates NLRP3 to promote apoptosis and inhibit proliferation of hep3B cells
title_full_unstemmed miRNA-223-3p regulates NLRP3 to promote apoptosis and inhibit proliferation of hep3B cells
title_short miRNA-223-3p regulates NLRP3 to promote apoptosis and inhibit proliferation of hep3B cells
title_sort mirna-223-3p regulates nlrp3 to promote apoptosis and inhibit proliferation of hep3b cells
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5792760/
https://www.ncbi.nlm.nih.gov/pubmed/29467847
http://dx.doi.org/10.3892/etm.2017.5667
work_keys_str_mv AT wanlingfeng mirna2233pregulatesnlrp3topromoteapoptosisandinhibitproliferationofhep3bcells
AT yuanxin mirna2233pregulatesnlrp3topromoteapoptosisandinhibitproliferationofhep3bcells
AT liumantian mirna2233pregulatesnlrp3topromoteapoptosisandinhibitproliferationofhep3bcells
AT xueboyu mirna2233pregulatesnlrp3topromoteapoptosisandinhibitproliferationofhep3bcells